Global Cell Therapy and Tissue Engineering Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Cell Therapy
  • 1.4.3 Tissue Engineering
• 1.5 Market by Application
  • 1.5.1 Global Cell Therapy and Tissue Engineering Market Share by Application (2019-2025)
  • 1.5.2 Cell Defects
  • 1.5.3 Genetic Diseases
  • 1.5.4 Neurodegenerative Diseases
  • 1.5.5 Tissue Malignancies
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Cell Therapy and Tissue Engineering Market Size
• 2.2 Cell Therapy and Tissue Engineering Growth Trends by Regions
  • 2.2.1 Cell Therapy and Tissue Engineering Market Size by Regions (2019-2025)
  • 2.2.2 Cell Therapy and Tissue Engineering Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Cell Therapy and Tissue Engineering Market Size by by Players
  • 3.1.1 Global Cell Therapy and Tissue Engineering Revenue by by Players (2014-2019)
  • 3.1.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Cell Therapy and Tissue Engineering Market Concentration Ratio (CR5 and HHI)
• 3.2 Cell Therapy and Tissue Engineering Key Players Head office and Area Served
• 3.3 Key Players Cell Therapy and Tissue Engineering Product/Solution/Service
• 3.4 Date of Enter into Cell Therapy and Tissue Engineering Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Cell Therapy and Tissue Engineering Market Size by Type (2014-2019)
• 4.2 Global Cell Therapy and Tissue Engineering Market Size by Application (2014-2019)

5 North America

• 5.1 North America Cell Therapy and Tissue Engineering Market Size (2014-2019)
• 5.2 Cell Therapy and Tissue Engineering Key Players in North America
• 5.3 North America Cell Therapy and Tissue Engineering Market Size by Type
• 5.4 North America Cell Therapy and Tissue Engineering Market Size by Application

6 Europe

• 6.1 Europe Cell Therapy and Tissue Engineering Market Size (2014-2019)
• 6.2 Cell Therapy and Tissue Engineering Key Players in Europe
• 6.3 Europe Cell Therapy and Tissue Engineering Market Size by Type
• 6.4 Europe Cell Therapy and Tissue Engineering Market Size by Application

7 China

• 7.1 China Cell Therapy and Tissue Engineering Market Size (2014-2019)
• 7.2 Cell Therapy and Tissue Engineering Key Players in China
• 7.3 China Cell Therapy and Tissue Engineering Market Size by Type
• 7.4 China Cell Therapy and Tissue Engineering Market Size by Application

8 Japan

• 8.1 Japan Cell Therapy and Tissue Engineering Market Size (2014-2019)
• 8.2 Cell Therapy and Tissue Engineering Key Players in Japan
• 8.3 Japan Cell Therapy and Tissue Engineering Market Size by Type
• 8.4 Japan Cell Therapy and Tissue Engineering Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Cell Therapy and Tissue Engineering Market Size (2014-2019)
• 9.2 Cell Therapy and Tissue Engineering Key Players in Southeast Asia
• 9.3 Southeast Asia Cell Therapy and Tissue Engineering Market Size by Type
• 9.4 Southeast Asia Cell Therapy and Tissue Engineering Market Size by Application

10 India

• 10.1 India Cell Therapy and Tissue Engineering Market Size (2014-2019)
• 10.2 Cell Therapy and Tissue Engineering Key Players in India
• 10.3 India Cell Therapy and Tissue Engineering Market Size by Type
• 10.4 India Cell Therapy and Tissue Engineering Market Size by Application

11 Central & South America

• 11.1 Central & South America Cell Therapy and Tissue Engineering Market Size (2014-2019)
• 11.2 Cell Therapy and Tissue Engineering Key Players in Central & South America
• 11.3 Central & South America Cell Therapy and Tissue Engineering Market Size by Type
• 11.4 Central & South America Cell Therapy and Tissue Engineering Market Size by Application

12 International Players Profiles

• 12.1 Betalin Therapeutics
  • 12.1.1 Betalin Therapeutics Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Cell Therapy and Tissue Engineering Introduction
  • 12.1.4 Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2014-2019))
  • 12.1.5 Betalin Therapeutics Recent Development
• 12.2 BioCardia, Inc
  • 12.2.1 BioCardia, Inc Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Cell Therapy and Tissue Engineering Introduction
  • 12.2.4 BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
  • 12.2.5 BioCardia, Inc Recent Development
• 12.3 BioReliance Corporation
  • 12.3.1 BioReliance Corporation Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Cell Therapy and Tissue Engineering Introduction
  • 12.3.4 BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
  • 12.3.5 BioReliance Corporation Recent Development
• 12.4 Biosolution Co., Ltd.
  • 12.4.1 Biosolution Co., Ltd. Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Cell Therapy and Tissue Engineering Introduction
  • 12.4.4 Biosolution Co., Ltd. Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
  • 12.4.5 Biosolution Co., Ltd. Recent Development
• 12.5 Brainstorm Cell Therapeutics, Inc
  • 12.5.1 Brainstorm Cell Therapeutics, Inc Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Cell Therapy and Tissue Engineering Introduction
  • 12.5.4 Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
  • 12.5.5 Brainstorm Cell Therapeutics, Inc Recent Development
• 12.6 MaxCyte, Inc
  • 12.6.1 MaxCyte, Inc Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Cell Therapy and Tissue Engineering Introduction
  • 12.6.4 MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
  • 12.6.5 MaxCyte, Inc Recent Development
• 12.7 Medigene AG
  • 12.7.1 Medigene AG Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Cell Therapy and Tissue Engineering Introduction
  • 12.7.4 Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
  • 12.7.5 Medigene AG Recent Development
• 12.8 MEDIPOST CO., Ltd.
  • 12.8.1 MEDIPOST CO., Ltd. Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Cell Therapy and Tissue Engineering Introduction
  • 12.8.4 MEDIPOST CO., Ltd. Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
  • 12.8.5 MEDIPOST CO., Ltd. Recent Development
• 12.9 Mesoblast Limited
  • 12.9.1 Mesoblast Limited Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Cell Therapy and Tissue Engineering Introduction
  • 12.9.4 Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
  • 12.9.5 Mesoblast Limited Recent Development
• 12.10 Miromatrix Medical, Inc.
  • 12.10.1 Miromatrix Medical, Inc. Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Cell Therapy and Tissue Engineering Introduction
  • 12.10.4 Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
  • 12.10.5 Miromatrix Medical, Inc. Recent Development
• 12.11 MolMed S.p.A
• 12.12 Mustang Bio, Inc
• 12.13 NantKwest, Inc.
• 12.14 Neuralstem, Inc
• 12.15 NexImmune, Inc.
• 12.16 Nohla Therapeutics, Inc
• 12.17 ReNeuron Group plc
• 12.18 Richter-Helm BioLogics GmbH & Co. KG
• 12.19 RoosterBio, Inc
• 12.20 RoslinCT
• 12.21 Rubius Therapeutics, Inc.
• 12.22 Sangamo Therapeutics, Inc
• 12.23 Voyager Therapeutics, Inc
• 12.24 Waisman Biomanufacturing
• 12.25 WindMIL Therapeutics, Inc.
• 12.26 Wuxi App Tec, Inc.
• 12.27 ReNeuron Group plc
• 12.28 Richter-Helm BioLogics GmbH & Co. KG
• 12.28 RoosterBio, Inc
• 12.40 RoslinCT

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Product (2019-2025)
• 13.2 Market Size Forecast by Application (2019-2025)
• 13.3 Market Size Forecast by Regions
• 13.4 North America
• 13.5 Europe
• 13.6 China
• 13.7 Japan
• 13.8 Southeast Asia
• 13.9 India
• 13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer